Related Experiment Video
Updated: Jun 12, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
[Genomic based approach to individualized cancer therapy]
1Department of Cancer Genomics, The Cancer Institute, Japanese Foundation for Cancer Research.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 12, 2010
Summary
Cancer chemotherapy efficacy varies due to tumor heterogeneity. Molecular diagnostic tools analyze gene expression to predict treatment response, enabling personalized chemotherapy for better patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Context:
- Chemotherapy is a cornerstone of cancer treatment, but its effectiveness is limited by significant patient-to-patient variability.
- Tumor heterogeneity is a primary driver of differential responses to chemotherapy, complicating treatment strategies.
- Advances in molecular biology enable high-throughput gene expression analysis, offering new avenues for understanding cancer biology.
Purpose:
- To review molecular diagnostic tools for predicting chemotherapy effectiveness.
- To highlight the role of gene expression profiling in identifying cancers that will respond to specific chemotherapies.
- To discuss the potential of these tools in individualizing cancer chemotherapy, with a focus on breast cancer.
Summary:
- Gene expression signatures can differentiate between chemotherapy-sensitive and chemotherapy-resistant cancers.
- Molecular diagnostic tools leverage these signatures to predict clinical outcomes and guide treatment decisions.
- The application of these tools is advancing towards personalized cancer chemotherapy, currently undergoing clinical trials.
Impact:
- Facilitates the development of targeted cancer therapies.
- Improves patient selection for chemotherapy, potentially reducing ineffective treatments and side effects.
- Paves the way for personalized medicine in oncology, particularly in breast cancer treatment.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...